Xtant Medical Announces FDA Clearance of the Xspan™ Laminoplasty Fixation System
Mar 30, 2016 11:30 am UTC| Business
BELGRADE, Mont., March 30, 2016 -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that its wholly owned subsidiary,...
Provision Interactive Announces New Patent Applications
Mar 30, 2016 11:30 am UTC| Business
CHATSWORTH, Calif., March 30, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO), announced today that it is preparing five new patent applications on...
OpGen Announces 2015 Fourth Quarter and Full Year Financial Results
Mar 30, 2016 11:30 am UTC| Business
Conference call begins at 10:00 a.m. Eastern time today GAITHERSBURG, Md., March 30, 2016 -- OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious...
Conatus Pharmaceuticals Announces Acceptance of Abstracts for EASL Meeting
Mar 30, 2016 11:30 am UTC| Business
- Late Breaker Oral Presentation of Phase 2 Liver Cirrhosis Trial Three-month Data - - Poster of Preclinical Data Addressing Safety of Caspase Inhibition in Cancer Treatment - SAN DIEGO, March 30, 2016 -- Conatus...
FTI Technology Recognized as Top Data Visualization Solution Provider by CIOReview
Mar 30, 2016 11:30 am UTC| Business
WASHINGTON, March 30, 2016 -- FTI Consulting, Inc. (NYSE:FCN), the global business advisory firm dedicated to helping organizations protect and enhance their enterprise value, today announced that its Technology segment...
Alliqua BioMedical to Present at the 15th Annual Needham Healthcare Conference
Mar 30, 2016 11:30 am UTC| Business
YARDLEY, Pa., March 30, 2016 -- Alliqua BioMedical, Inc. (NASDAQ:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced that David Johnson, Chief Executive Officer, and Brian...
Aldeyra Therapeutics Reports Full Year 2015 Financial Results
Mar 30, 2016 11:30 am UTC| Business
LEXINGTON, Mass., March 30, 2016 -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced its...